![]() |
FORSCHUNGSBERICHT 1999-2001 | INDEX
|
Pharmazeutisches Institut Abteilung Pharmakologie u. Toxikologie
Institut für Pharmazeutische Biologie
| Forschungsbericht
Mathematisch-Naturwissenschaftliche Fakultät
|
Allgemeine Angaben:
An der Immenburg 4, 53121 Bonn
Telefon: 0228 / 73-52-52
Fax: 0228 / 73-9757
eMail: u.jaehde@uni-bonn.de
WWW: http://www.pharma.uni-bonn.de/klinpharm/index.html
Baumann F, Lorenz C, Jaehde U, Preiss R
Determination of cyclophosphamide and its metabolites in human plasma by high-performance liquid chromatography-mass spectrometry.
J. Chromatogr. B 729: 297-305, 1999
Fleischhack G, Reif S, Hasan C, Jaehde U, Hettmer S, Bode U
Feasibility of intraventricular administration of etoposide in patients with metastatic brain tumors.
Br. J. Cancer 84: 1453-1459, 2001
Gysler J, Jaehde U, Schunack W
Electromigration dispersion of isotachophoretic protein zones during capillary zone electrophoresis.
Fresenius J. Anal. Chem. 365: 398-403, 1999
Gysler J, Mazereeuw M, Helk B, Heitzmann M, Jaehde U, Schunack W, Tjaden UR, van der Greef J
Utility of isotachophoresis-capillary zone electrophoresis, mass spectrometry and high-performance size-exclusion chromatography for monitoring of interleukin-6 dimer formation.
J. Chromatogr. A 841: 63-73, 1999
Gysler J, Schunack W, Jaehde U
Monitoring of chemotherapy-induced proteinuria using capillary zone electrophoresis.
J. Chromatogr. B 721: 207-216, 1999
Jaehde U, Ammon HPT
Klinische Pharmazie - eine neue Fachdisziplin an Pharmazeutischen Instituten.
DGPT-Forum 25: 27-28, 1999
Jaehde U, Lengeling S, Liekweg A
Arzneimittelanwendung im Alter.
In: H. Schneemann, L.Y. Young, M. A. Koda-Kimble (Hrsg.): Angewandte Arzneimitteltherapie. Klinisch-Pharmazeutische Betreuung in Fallbeispielen. Springer-Verlag, Berlin, Heidelberg, 757-770, 2001
Kloft C, Appelius H, Siegert W, Schunack W, Jaehde U
Determination of platinum complexes with antitumor activity in clinical samples by a rapid flameless atomic absorption spectrometry assay.
Ther. Drug Monit. 21: 631-637, 1999
Kloft C, Eickhoff C, Schulze-Forster K, Maurer HR, Schunack W, Jaehde U
Development and application of a simple assay to quantify cellular adducts of platinum complexes with DNA.
Pharm. Res. 16: 470-473, 1999
Liekweg A, Jaehde U
Onkologische Pharmazie an der Universität Bonn.
Onkol. Pharm. 2 (1): 4-5, 2000
Lorenz C, Eickhoff C, Baumann F, Sehouli J, Preiss R, Schunack W, Jaehde U
Does ondansetron affect the metabolism of cyclophosphamide?
Int. J. Clin. Pharmacol. Ther. 38: 143-144, 2000
Lorenz C, Jaehde U
Cyclophosphamid.
Dtsch. med. Wochenschr. 126: 815-818, 2001
Pieck A.C., Jaehde U
Prüfung auf Platinkontamination in der Arbeitsumgebung.
Onkol. Pharm. 3 (3): 6-7, 2001
Reif S, Grimm J, Kingreen D, Siegert W, Schunack W, Jaehde U
Pharmacokinetics of etoposide following administration of high-dose etoposide and etoposide phosphate.
Int. J. Clin. Pharmacol. Ther. 38: 156-157, 2000
Reif S, Kingreen D, Kloft C, Grimm J, Siegert W, Schunack W, Jaehde U
Bioequivalence investigation of high-dose etoposide and etoposide phosphate in lymphoma patients.
Cancer Chemother. Pharmacol. 48: 134-140, 2001
Stremetzne S, Streit M, Kreuser ED, Schunack W, Jaehde U
Randomized pharmacokinetic and pharmacodynamic comparison of two doses of calcium folinate combined with continuous fluorouracil infusion in patients with advanced colorectal cancer.
Pharm. World Sci. 21: 184-189, 1999
Warnke U, Gysler J, Hofte B, Tjaden UR, van der Greef J, Kloft C, Schunack W, Jaehde U
Separation and identification of platinum adducts with DNA nucleotides by capillary zone electrophoresis and capillary zone electrophoresis coupled to mass spectrometry.
Electrophoresis 22: 97-103, 2001
Wilde S, Jetter A, Menzel H, Rietbrock S, Zaigler M, Sieber M, Tesch H, Hempel G, Reif S, Jaehde U, Merkel U, Johnson S, Diehl V, Fuhr U
Population pharmacokinetics of drugs in the BEACOPP chemotherapy regimen used in Hodgkin´s disease.
Int. J. Clin. Pharmacol. Ther. 38: 147-149, 2000
| eMail: Transfer und Öffentlichkeitsarbeit |
|